Google's Debug Initiative Seeks Approval to Release 32 Million Bioengineered Mosquitoes in Florida and California
By
Joe Wilkins
1mo ago· 5 min readenNews
Summary
Google's parent company Alphabet, through its Debug initiative, is seeking government approval to release 32 million bioengineered male mosquitoes infected with Wolbachia bacteria into Florida and California. The goal is to disrupt the reproduction cycle of disease-carrying mosquito populations by releasing "good bugs" whose sperm cannot fertilize eggs of uninfected females, potentially reducing the overall mosquito population over time. The plan has generated public backlash and controversy.
Source
Key quotes
· 3 pulledOne of the wealthiest corporations in the world is seeking government permission to release 32 million mosquitoes throughout Florida and California.
Called 'Debug,' the Google-owned company is attempting to flood disease-carrying mosquito populations with 'good bugs,' meaning male mosquitoes that have been infected with a bacteria called Wolbachia.
Over time, the theory goes, this will disrupt the reproduction cycle, thereby increasing competition and decreasing the overall population.
The tech company has a new initiative called Debug, which plans to release millions of "good bugs" throughout the United States.
You might also wanna read
“A chance to support large-scale mosquito eradication in the USA (closes June 5)” by Aaron Gertler 🔸
EA Forum·1mo ago
:max_bytes(150000):strip_icc()/Aedes-aegypti-mosquito-060126-1-fa1c7d7ac9954cf79a52c44d26e47f6b.jpg)
Google Seeks Approval to Release 32 Million Mosquitoes in California and Florida
people.com·1mo ago
Debug Project: Using Sterile Mosquitoes to Combat Disease-Carrying Mosquitoes
Debug is a group of scientists and engineers developing technology to raise and release sterile mosquitoes to combat disease-carrying mosqui
Scientists genetically engineer a lethal mosquito STD to combat malaria
newatlas.com·1y ago
Scientists focus on genetically engineering mice to cut Lyme disease transmission
MIT·9mo ago
Inside Health
BBC·1d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.